Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
2022/08/22
Talent and Innovation | Wanbangde Pharmaceutical Group Holds the First PhD Candidate's Proposal Defense Meeting at Its Postdoctoral Research Workstation
Adhering to the Work Safety Law and Taking on Primary Responsibility | Wanbangde Pharmaceutical Group Holds 2022 "Work Safety Month" Kickoff Meeting
2022/06/11
Wanbangde Pharmaceutical Group Co., Ltd. Announces Environmental Measures for New Technical Upgrade Project: Annual Production Capacity of 5 tons of Resorcinol API and 500 tons of Cimetidine API
2022/04/29
Entering 100 Cities, Engaging 1,000 Enterprises, Connecting 10,000 Households | The Wengling Pharmaceutical Enterprises Symposium Successfully Held at Wanbangde China-Africa Science Park
2022/04/09
Deepening Industry-Academia Collaboration to Jointly Craft a Win-Win Blueprint | Dean Hu Jinfeng and His Delegation from the School of Pharmacy at Taizhou University Visit Wanbangde for Research
2022/03/28
Starting Strong: Wanbangde Group and Its Subsidiaries Garner Three Prestigious Awards
Top News | A field office meeting attended by Taizhou Municipal Standing Committee Member and Wenling Party Secretary visits Wanbangde
Top News | Zhejiang Province Vice Governor Wang Wenxu Visits Wanbangde China-Africa Science and Technology Industrial Park for Inspection and Research
The 2021 Outstanding Employees Recognition Ceremony of Wanbande Pharmaceutical Group Concludes Successfully
2021/12/28
Honors | Kudos! Wanbangde Pharmaceutical Group once again makes the prestigious "2021 Top 100 Traditional Chinese Medicine Enterprises" list.
Honors | Wanbangde Group Recognized Among 2021 Zhejiang's Top 200 Private Enterprises
2021/03/02
Academician Tang Xican of the Chinese Academy of Engineering visits Wanbangde Pharmaceutical for an inspection.
He Song, inspector of the Department of West Asia and Africa at the Ministry of Commerce, and his delegation visited Wandeb Group for a research visit.
Environmental Impact Assessment Report for the 980-Ton Per Year Norfloxacin Production Technology Upgrade Project (Front-end Supplement) of Wanbangde Pharmaceutical Group Co., Ltd.
Lü Zhiliang, Minister of Organization and Standing Committee Member of the Taizhou Municipal Party Committee, visited Wanbangde Pharmaceutical Group to coordinate and address challenges hindering the company's development.
